China SXT Pharmaceuticals Inc (NASDAQ:SXTC) was the target of a large decline in short interest in the month of August. As of August 31st, there was short interest totalling 142,300 shares, a decline of 49.0% from the July 31st total of 278,900 shares. Based on an average daily volume of 40,800 shares, the days-to-cover ratio is presently 3.5 days. Approximately 1.7% of the shares of the company are sold short.
Several institutional investors have recently added to or reduced their stakes in the business. Invesco Ltd. bought a new position in shares of China SXT Pharmaceuticals during the 2nd quarter valued at approximately $88,000. Jane Street Group LLC purchased a new stake in shares of China SXT Pharmaceuticals during the 2nd quarter worth approximately $72,000. Finally, Spark Investment Management LLC purchased a new stake in China SXT Pharmaceuticals during the 1st quarter valued at $94,000. Institutional investors and hedge funds own 7.67% of the company’s stock.
Shares of China SXT Pharmaceuticals stock traded down $0.05 during trading hours on Friday, reaching $2.35. 901 shares of the stock traded hands, compared to its average volume of 12,401. The company has a 50 day moving average price of $2.44 and a 200 day moving average price of $4.21. China SXT Pharmaceuticals has a one year low of $1.97 and a one year high of $23.35.
China SXT Pharmaceuticals, Inc, a pharmaceutical company, engages in the research, development, manufacture, marketing, and sale of traditional Chinese medicine tablets in China. It provides oral prescription drugs and supplements under the Suxuantang, Hui Chun Tang, and Tong Ren Tang brands. The company offers its products to pharmaceutical distributors, pharmaceutical companies, pharmacies, and hospitals through sales representatives.
Recommended Story: How to calculate the annual rate of depreciation
Receive News & Ratings for China SXT Pharmaceuticals Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for China SXT Pharmaceuticals and related companies with MarketBeat.com's FREE daily email newsletter.